Creative Financial Designs’s GSK GSK Stock Holding History

Creative Financial Designs’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.7K	Sell	719 -99	-12%	-$5.24K	﹤0.01%	1100
2026 Q1	$45.1K	Buy	818 +110	+16%	+$5.96K	﹤0.01%	932
2025 Q4	$34.7K	Buy	708 +26	+4%	+$1.21K	﹤0.01%	998
2025 Q3	$29.4K	Buy	682 +12	+2%	+$469	﹤0.01%	1024
2025 Q2	$25.7K	Sell	670 -63	-9%	-$2.41K	﹤0.01%	1055
2025 Q1	$28.4K	Buy	733 +120	+20%	+$4.39K	﹤0.01%	995
2024 Q4	$20.7K	Buy	613 +6	+1%	+$216	﹤0.01%	1039
2024 Q3	$24.8K	Buy	607 +6	+1%	+$245	﹤0.01%	981
2024 Q2	$23.1K	Sell	601 -57	-9%	-$2.4K	﹤0.01%	963
2024 Q1	$28.2K	Sell	658 -35	-5%	-$1.44K	﹤0.01%	876
2023 Q4	$25.7K	Buy	693 +45	+7%	+$1.61K	﹤0.01%	850
2023 Q3	$23.5K	Buy	648 +6	+0.9%	+$213	﹤0.01%	818
2023 Q2	$22.9K	Sell	642 -195	-23%	-$7K	﹤0.01%	821
2023 Q1	$29.8K	Buy	837 +68	+9%	+$2.38K	﹤0.01%	710
2022 Q4	$27K	Buy	769 +7	+0.9%	+$233	﹤0.01%	697
2022 Q3	$22K	Hold	762	–	–	﹤0.01%	715
2022 Q2	$41K	Hold	762	–	–	0.01%	584
2022 Q1	$42K	Hold	762	–	–	0.01%	591
2021 Q4	$42K	Sell	762 -240	-24%	-$12.5K	0.01%	602
2021 Q3	$48K	Buy	1,002 +400	+66%	+$20.1K	0.01%	625
2021 Q2	$30K	Hold	602	–	–	0.01%	744
2021 Q1	$27K	Hold	602	–	–	0.01%	709
2020 Q4	$28K	Hold	602	–	–	0.01%	642
2020 Q3	$28K	Hold	602	–	–	0.01%	584
2020 Q2	$31K	Buy	+602	New	+$30.9K	0.01%	502
2019 Q2	–	Sell	-30	Closed	-$2K	–	566
2019 Q1	$2K	Buy	+30	New	+$1.5K	﹤0.01%	502
2017 Q4	–	Sell	-49	Closed	-$1K	–	724
2017 Q3	$1K	Sell	49 -240	-83%	-$12.2K	﹤0.01%	684
2017 Q2	$14K	Hold	289	–	–	0.01%	371
2017 Q1	$13K	Sell	289 -160	-36%	-$8.12K	0.01%	372
2016 Q4	$21K	Buy	+449	New	+$22.2K	0.02%	309

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Creative Financial Designs's GSK Position: Q2 2026 in Review

Creative Financial Designs reduced its GSK (GSK) stake by 12% in Q2 2026, selling an estimated $5.24K and leaving 719 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Creative Financial Designs first reported a position in GSK in Q4 2016 and has held it in 30 quarters since. The position peaked at $48K in Q3 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Creative Financial Designs held 719 shares of GSK worth $37.7K as of Q2 2026.
Creative Financial Designs sold 99 GSK shares in Q2 2026, an estimated $5.24K.
GSK made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1100 holding.
Creative Financial Designs first reported a position in GSK in Q4 2016 and has held it in 30 quarters since.
Creative Financial Designs's GSK position peaked at $48K in Q3 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.